OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MSC Based Therapies—New Perspectives for the Injured Lung
Judith Behnke, Sarah Kremer, Tayyab Shahzad, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 3, pp. 682-682
Open Access | Times Cited: 152

Showing 26-50 of 152 citing articles:

Mesenchymal Stromal Cells in Viral Infections: Implications for COVID-19
José Lucas Martins Rocha, Waldir César Ferreira de Oliveira, Nádia Cássia Noronha, et al.
Stem Cell Reviews and Reports (2020) Vol. 17, Iss. 1, pp. 71-93
Open Access | Times Cited: 35

Stem Cells Therapy as a Possible Therapeutic Option in Treating COVID-19 Patients
Diana Esquivel, Rangnath Mishra, Prabhat Soni, et al.
Stem Cell Reviews and Reports (2020) Vol. 17, Iss. 1, pp. 144-152
Open Access | Times Cited: 33

Clinical experience on umbilical cord mesenchymal stem cell treatment in 210 severe and critical COVID-19 cases in Turkey
Nesrin Erçelen, Kubra Cigdem Pekkoc-Uyanik, Nagihan Alpaydin, et al.
Stem Cell Reviews and Reports (2021) Vol. 17, Iss. 5, pp. 1917-1925
Open Access | Times Cited: 32

Mesenchymal stem cell-based therapy as a new therapeutic approach for acute inflammation
Kamal Abdolmohammadi, Tayebeh Mahmoudi, Mina Alimohammadi, et al.
Life Sciences (2022) Vol. 312, pp. 121206-121206
Closed Access | Times Cited: 20

Extracellular Matrix Synthesis and Remodeling by Mesenchymal Stromal Cells Is Context-Sensitive
Janina Burk, Anna Sassmann, Cornelia Kasper, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1758-1758
Open Access | Times Cited: 19

Recent advances in the therapeutic efficacy of hepatocyte growth factor gene‐modified mesenchymal stem cells in multiple disease settings
Hongfang Meng, Jide Jin, Hua Wang, et al.
Journal of Cellular and Molecular Medicine (2022) Vol. 26, Iss. 18, pp. 4745-4755
Open Access | Times Cited: 19

Regenerative and translational medicine in COPD: hype and hope
Lucas Pires Guarnier, Lincoln Gozzi Moro, Francislaine Aparecida dos Reis Lívero, et al.
European Respiratory Review (2023) Vol. 32, Iss. 169, pp. 220223-220223
Open Access | Times Cited: 12

Effect of Hyaluronic Acid and Mesenchymal Stem Cells Secretome Combination in Promoting Alveolar Regeneration
Francesca Della Sala, Gennaro Longobardo, Gianluca Lista, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3642-3642
Open Access | Times Cited: 11

Anti-inflammatory and immunomodulatory effects of mesenchymal stem cell therapy on parasitic drug resistance
Soheil Sadr, Pouria Ahmadi Simab, Mahta Niazi, et al.
Expert Review of Anti-infective Therapy (2024) Vol. 22, Iss. 6, pp. 435-451
Closed Access | Times Cited: 4

Microvesicles derived from mesenchymal stem cells: A promising therapeutic strategy for acute respiratory distress syndrome-related pulmonary fibrosis?
Zhao Zhang, X. Y. Shan, Ce Liang, et al.
World Journal of Stem Cells (2025) Vol. 17, Iss. 1
Closed Access

Innovative approaches to treatment of eye diseases: advances in stem cell therapy use in ophthalmology
Victor Oluwatomiwa Ajekiigbe, Chinonyelum Emmanuel Agbo, Ikponmwosa Jude Ogieuhi, et al.
International Ophthalmology (2025) Vol. 45, Iss. 1
Closed Access

Conditioned Medium from Human Amnion-Derived Mesenchymal Stromal/Stem Cells Attenuating the Effects of Cold Ischemia-Reperfusion Injury in an In Vitro Model Using Human Alveolar Epithelial Cells
Vitale Miceli, Alessandro Bertani, Cinzia Maria Chinnici, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 510-510
Open Access | Times Cited: 26

Current therapeutic strategies for respiratory diseases using mesenchymal stem cells
Mingyao Wang, Tingyue Zhou, Zhidong Zhang, et al.
MedComm (2021) Vol. 2, Iss. 3, pp. 351-380
Open Access | Times Cited: 25

Mesenchymal Stem Cell-Derived Extracellular Vesicle: A Promising Alternative Therapy for Osteoporosis
Cheng-Hsiu Lu, Yi‐An Chen, Chien‐Chih Ke, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12750-12750
Open Access | Times Cited: 25

Dissecting the Role of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis: Cause or Solution
Anna Valeria Samarelli, Roberto Tonelli, Irene H. Heijink, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 24

When stem cells meet COVID-19: recent advances, challenges and future perspectives
Shasha Li, Hecheng Zhu, Ming Zhao, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 18

Therapeutic potential of Sertoli cells in vivo: alleviation of acute inflammation and improvement of sperm quality
Bianka Porubská, Marie Plevakova, Natálie Fikarová, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3

Mesenchymal stem cell (MSc) secretome: A possible therapeutic strategy for intensive-care COVID-19 patients
Elenice Deffune, Aruã Prudenciatti, Andrei Moroz
Medical Hypotheses (2020) Vol. 142, pp. 109769-109769
Open Access | Times Cited: 27

Therapeutic prospects of mesenchymal stem/stromal cells in COVID-19 associated pulmonary diseases: From bench to bedside
Leisheng Zhang, Yi Yu, Hao Yu, et al.
World Journal of Stem Cells (2021) Vol. 13, Iss. 8, pp. 1058-1071
Open Access | Times Cited: 22

Stem cell-based therapy for COVID-19 and ARDS: a systematic review
Gabriele Zanirati, Laura Provenzi, Lucas Lobraico Libermann, et al.
npj Regenerative Medicine (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 21

Therapeutic modalities and novel approaches in regenerative medicine for COVID-19
Roya Ramezankhani, Roya Solhi, Arash Memarnejadian, et al.
International Journal of Antimicrobial Agents (2020) Vol. 56, Iss. 6, pp. 106208-106208
Open Access | Times Cited: 23

Could Mesenchymal Stem Cell-Derived Exosomes Be a Therapeutic Option for Critically Ill COVID-19 Patients?
Chiara Gardin, Letizia Ferroni, Juan Carlos Chachques, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 9, pp. 2762-2762
Open Access | Times Cited: 22

A review of potential treatments to date in COVID-19 patients according to the stage of the disease
Tamim Alsuliman, Lugien Alasadi, Banan Alkharat, et al.
Current Research in Translational Medicine (2020) Vol. 68, Iss. 3, pp. 93-104
Open Access | Times Cited: 21

Scroll to top